Results 21 to 30 of about 332,247 (257)

Recent amendments to the Endangered Species Act and an uncertain future for species at risk: a case study of Ontario’s Niagara Region

FACETS, 2021
The biodiversity crisis is a pressing global issue. In Ontario, Canada, species at risk are protected under the Endangered Species Act (2007). The current government amended that legislation through the More Homes, More Choice Act (2019), leaving species
Allegra Bethlenfalvy, Andrea Olive
doaj   +1 more source

CHRYSOMELIANS OF ONTARIO [PDF]

The Canadian Entomologist, 1914
n ...
openaire   +1 more source

THE ARCHAeOLOGICAL REPORT OF ONTARIO [PDF]

Science, 1900
n ...
openaire   +3 more sources

Practical Strategies of Disruption for Dismantling White Supremacy in Ontario’s Education System

Lateral
This article examines the Ontario education system’s use of surface level practices intended to counter racism but that often fall short of creating authentic and sustainable change.
Aida Al-Thayabeh
doaj   +1 more source

Banning Compensation for Donations of Blood and Blood Components in Ontario

Health Reform Observer - Observatoire des Réformes de Santé, 2020
In 2014, Ontario passed Bill 21: Safeguarding Healthcare Integrity Act, which enacted the Voluntary Blood Donations Act, 2014, to ban all forms of compensation for donations of blood and blood components.
Ansh Goyal
doaj   +1 more source

Toronto's first street kids and the origins of child welfare systems in Canada part 2: later years

Scottish Journal of Residential Child Care, 2018
This study focuses on the evolution of a philanthropic movement in the second half of 19th Century Canada that gave particular attention to a population of children and youth in Toronto known as newsboys and newsgirls.
Ted Dunlop
doaj   +1 more source

An Exploration of Quality of Life among Ontario Postsecondary Students Living with the Chronic Illness Ehlers-Danlos Syndrome

Canadian Journal for the Scholarship of Teaching and Learning, 2020
Ehlers-Danlos Syndrome (EDS) is a connective tissue disorder that results in negative health events. It also holds potential for periodic or permanent disability and psychosocial stress.
Catherine M. Giroux, Lorraine Carter, Julie Corkett   +2 more
doaj   +1 more source

Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survival after relapse in pediatric acute myeloid leukemia (AML) remains poor, highlighting the critical importance of identifying prognostic factors to guide optimal relapse management. Methods We investigated the prognostic impact of multiparameter flow cytometry (MFC) measurable residual disease (MRD) in 188 patients with first ...
Camilla Poulsen, Kristian Juul Sandahl, Lene Karlsson, Jonas Abrahamsson, Nira Arad‐Cohen, Daniel Cheuk, Barbara De Moerloose, Linda Fogelstrand, Jose Maria Fernandez Navarro, Bianca F. Goemans, Kirsi Jahnukainen, Gertjan Kaspers, Zhanna Kovalova, Monica Cheng Munthe‐Kaas, Ulrika Norén‐Nyström, Josefine Palle, Ramune Pasauliene, Cornelis Jan Pronk, Kadri Saks, Anne Tierens, Henrik Hasle, Kristian Løvvik Juul‐Dam   +21 more
wiley   +1 more source

On Hierarchical Composite Endpoints in Pediatric Cancer Supportive Care: Illustrative Examples From Two Multi‐Center Phase‐III Randomized Clinical Trials

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric supportive care clinical trials often involve multiple clinically important outcomes, complicating trial interpretation. Hierarchical composite endpoints (HCEs) provide a framework to integrate key outcomes according to clinical importance.
Willem H. Collier, Mark Zobeck, Adam J. Esbenshade, Christopher C. Dvorak, Lillian Sung, David Freyer, Sarah Alexander, Etan Orgel, Nicole J. Ullrich, Zach Prudowsky, Brian Fisher, Caitlin W. Elgarten   +11 more
wiley   +1 more source

Improvement of Sickle Cell Disease Care Mitigates the Healthcare Utilization Induced by Increased Prevalence: Experience of a Tertiary Pediatric Center

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Sickle cell disease (SCD) has undergone major changes in the last decades. Its prevalence has been steadily increasing and numerous advances have been made in the management of the disease. However, the effect in real‐life setting of these major changes is unknown, particularly in a Canadian environment. Procedure We aimed to assess
Maude Cigna, Alexia Muresan, Estelle Lecluze, Karine Leduc, Nathalie Fournier, Maria Tamer, Jean‐François Delisle, Jeremi Charbonneau, Annie Viau, Jessica Darilus, Marie‐Joëlle Doré‐Bergeron, Valérie Arsenault, Evelyne Doyon‐Trottier, Stéphanie Forte, Nancy Robitaille, Yves Pastore, Thomas Pincez   +16 more
wiley   +1 more source